NNVC

NanoViricides Inc.

0.85

USD

NNVC Earnings Reports

Positive Surprise Ratio

NNVC beat 12 of 13 last estimates.

92%

Next Report

Next Week

Date of Next Report

Feb 12, 2026

Estimate for Q2 26 (Revenue/ EPS)

-$0.14

Implied change from Q1 26 (Revenue/ EPS)

+40.00%

Implied change from Q2 25 (Revenue/ EPS)

NanoViricides Inc. earnings per share and revenue

On Nov 14, 2025, NNVC reported earnings of -0.10 USD per share (EPS) for Q1 26, beating the estimate of -0.18 USD, resulting in a 45.53% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).

Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an increase of 40.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were NanoViricides Inc.'s earnings and revenue for the latest quarter Q1 2026?

For Q1 2026, NanoViricides Inc. reported EPS of -$0.10, beating estimates by 45.53%, and revenue of $0.00, 0% as expectations.

How did the market react to NanoViricides Inc.'s Q1 2026 earnings?

The stock price moved up 2.82%, changed from $1.42 before the earnings release to $1.46 the day after.

When is NanoViricides Inc. expected to report next?

The next earning report is scheduled for Feb 12, 2026.

What are the forecasts for NanoViricides Inc.'s next earnings report?

Based on 4 analysts, NanoViricides Inc. is expected to report EPS of -$0.14 and revenue of -- for Q2 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.